Disaccharide tripeptide glycerol dipalmitoyl Uses, Dosage, Side Effects and more
Disaccharide tripeptide glycerol dipalmitoyl is under investigation in clinical trial NCT00003667 (Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma).
| Attribute | Details |
|---|---|
| Trade Name | Disaccharide tripeptide glycerol dipalmitoyl |
| Generic | Disaccharide tripeptide glycerol dipalmitoyl |
| Type | |
| Formula | C65H116N6O21 |
| Weight | Average: 1317.664 Monoisotopic: 1316.819354779 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
